Early vs. late treatment initiation in multiple sclerosis and its impact on cost of illness: A register-based prospective cohort study in Sweden

BACKGROUND: Early treatment with disease modifying therapies (DMTs) for multiple sclerosis (MS) has been associated with lower disability progression; the aim was to explore its association with cost of illness (COI) in MS. METHODS: All people with relapsing-remitting MS in the Swedish MS register,...

Descripción completa

Detalles Bibliográficos
Autores principales: Karampampa, Korinna, Gyllensten, Hanna, Murley, Chantelle, Alexanderson, Kristina, Kavaliunas, Andrius, Olsson, Tomas, Manouchehrinia, Ali, Hillert, Jan, Friberg, Emilie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044795/
https://www.ncbi.nlm.nih.gov/pubmed/35496759
http://dx.doi.org/10.1177/20552173221092411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044795/
https://www.ncbi.nlm.nih.gov/pubmed/35496759
http://dx.doi.org/10.1177/20552173221092411

Ejemplares similares